VAERS reports by lot

GSK Hepatitis A lot P4DJ5: VAERS reports

24 VAERS reports list lot P4DJ5 as a GSK Hepatitis A vaccine, received between 2020-12-09 and 2023-06-07. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
0%
Marked serious
0
With a death outcome
17
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological930%
Injection-site / Local reaction517%
General / Systemic (non-local)413%
Allergic / Anaphylactic310%
Gastrointestinal310%
Dermatological (non-injection-site)27%
Cardiac / Cardiovascular13%
Autoimmune / Immune-mediated13%
Musculoskeletal13%
Psychiatric / Neuropsychiatric13%

Where reports came from

U.S. state of the reporter, where given (top 12).

California3
Michigan2
New Jersey2
Virginia2
Iowa2
Illinois2
Pennsylvania2
Washington1
North Carolina1
South Carolina1
Indiana1
Florida1

Reports by month received

2020-121
2021-022
2021-032
2021-042
2021-051
2021-061
2021-091
2021-111
2021-121
2022-022
2022-031
2022-041
2022-051
2022-081
2022-092
2023-013
2023-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.